Interstitial lung disease Trials in Charleston, United States
Conditions / Interstitial lung disease / Charleston, United States
Interstitial lung disease has been the subject of sustained clinical investigation across multiple research sites.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05943535 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) | RECRUITING | — |
| NCT06388421 | DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | RECRUITING | — |
| NCT04708782 | Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | COMPLETED | PHASE3 |
| NCT02633293 | An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE | TERMINATED | PHASE2/PHASE3 |
| NCT06635850 | A Study of Mosliciguat in PH-ILD | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06129240 | An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH | ACTIVE_NOT_RECRUITING | — |
| NCT02630316 | Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE | COMPLETED | PHASE2/PHASE3 |
| NCT04905693 | Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease | ENROLLING_BY_INVITATION | PHASE3 |
| NCT05270668 | Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT01203943 | A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) | TERMINATED | PHASE2 |